CRC - KE38325
Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing
| Organization: | CRC |
| Publication Date: | 30 November 2016 |
| Status: | active |
| Page Count: | 387 |
scope:
The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.
Document History